MedTrace Logo

Hyperinflammation and Hyperferritinemia in Critically Ill Patients

NCT06820905 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1962

Last updated 2025-02-11

No results posted yet for this study

Summary

Analysing trajectory of critically ill patients with signs of hyperinflammation

Conditions

  • Critical Illness
  • Sepsis
  • Hyperferritinemia
  • Hyperinflammatory Syndrome

Sponsors & Collaborators

  • Charles University, Czech Republic

    lead OTHER

Principal Investigators

  • Thomas Karvunidis, MD, PhD · Faculty of Medicine and Teaching Hospital, Charles University, Pilsen, Czech Republic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-20
Primary Completion
2025-06-30
Completion
2025-11-30

Countries

  • Czechia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06820905 on ClinicalTrials.gov